Adda Nathalie
- SEC CIK
- 0001646976
No open-market purchases or sales filed in the past year.
Current role at each company
- ENTA Enanta Pharmaceuticals IncSr. VP & Chief Medical Officeras of Apr 5, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Adda Nathalie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 5, 2022 (view filing) | Apr 1-4 | 4 days | Adda NathalieSr. VP & Chief Medical Officer | SSale | −83.3K | $71.60 | −$5.97M | −70.4%35.0K after | 6 lots |
| Mar 3, 2022 (view filing) | Mar 1-2 | 2 days | Adda NathalieSr. VP & Chief Medical Officer | SSale | −36.8K | $70.20 | −$2.58M | −51.3%35.0K after | 3 lots |
| Jan 13, 2022 (view filing) | Jan 11 | 2 days | Adda NathalieSr. VP & Chief Medical Officer | SSale | −12.5K | $70.13 | −$879.1K | −27.6%32.9K after | |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Adda NathalieSr. VP & Chief Medical Officer | SSale | −13.5K | $86.35 | −$1.17M | −29.1%32.9K after | 7 lots |
| Nov 2, 2021 (view filing) | Nov 1 | 1 day | Adda NathalieSr. VP & Chief Medical Officer | SSale | −9.55K | $84.89 | −$810.4K | −26.2%26.9K after | 3 lots |
| Oct 13, 2021 (view filing) | Oct 8-11 | 5 days | Adda NathalieSr. VP & Chief Medical Officer | SSale | −17.5K | $70.15 | −$1.23M | −39.4%26.9K after | 2 lots |